Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Three patients with massive pulmonary embolism].

L E Oostenbrug1, T S van der Werf, J E Tulleken

  • 1Academisch Ziekenhuis, Interne Kliniek, afd. Intensive Care Beademing, Postbus 30.001, 9700 RB Groningen.

Nederlands Tijdschrift Voor Geneeskunde
|July 28, 2001
PubMed
Summary

Thrombolysis effectively treated massive pulmonary embolism in two patients, demonstrating improved blood flow and symptom resolution. While potentially life-saving, further trials are needed to confirm improved survival rates compared to heparin therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The value of routine endoscopic ultrasound in patients with esophageal cancer undergoing active surveillance after neoadjuvant chemoradiotherapy.

Endoscopy·2025
Same author

Isoniazid and rifampicin exposure during treatment in drug-susceptible TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.

Antimicrobial agents and chemotherapy·2022
Same author

Clinical standards for drug-susceptible TB: putting patients first.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Assessment of TB treatment on patient well-being.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"

Antimicrobial agents and chemotherapy·2021

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Vascular Medicine

Background:

  • Massive venous pulmonary thromboembolism (PTE) is a critical condition requiring prompt diagnosis and treatment.
  • Thrombolytic therapy offers a potential treatment option for massive PTE, aiming to dissolve blood clots.
  • Limited data exists comparing thrombolysis efficacy against standard anticoagulant therapy like heparin.

Observation:

  • Case 1: A 23-year-old female with PTE showed significant improvement after thrombolysis, with restored vessel patency and symptom resolution.
  • Case 2: A 51-year-old female with PTE and a patent foramen ovale responded favorably to intravenous streptokinase.
  • Case 3: An 80-year-old female with PTE experienced initial improvement but ultimately succumbed to right-sided heart failure despite streptokinase treatment.

Findings:

Related Experiment Videos

  • Diagnostic workup for PTE should prioritize ruling out other critical conditions like left-sided heart failure and pericardial tamponade.
  • Echocardiography can be a valuable diagnostic tool in patients with suspected PTE.
  • Streptokinase, a less expensive thrombolytic agent, demonstrated effectiveness in one case and is suggested to be non-inferior to more costly alternatives like alteplase.

Implications:

  • Thrombolysis may be a life-saving intervention for massive PTE, though robust evidence from randomized controlled trials is lacking to definitively establish survival benefits over heparin.
  • Cost-effectiveness analysis favors streptokinase over alteplase or urokinase, pending further clinical validation.
  • Further research is warranted to elucidate the optimal role and long-term outcomes of thrombolytic therapy in massive PTE management.